1. Home
  2. AIV vs PCRX Comparison

AIV vs PCRX Comparison

Compare AIV & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIV
  • PCRX
  • Stock Information
  • Founded
  • AIV 1975
  • PCRX 2006
  • Country
  • AIV United States
  • PCRX United States
  • Employees
  • AIV N/A
  • PCRX N/A
  • Industry
  • AIV Real Estate Investment Trusts
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIV Real Estate
  • PCRX Health Care
  • Exchange
  • AIV Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • AIV 1.2B
  • PCRX 1.2B
  • IPO Year
  • AIV 1994
  • PCRX 2011
  • Fundamental
  • Price
  • AIV $7.60
  • PCRX $23.44
  • Analyst Decision
  • AIV Buy
  • PCRX Buy
  • Analyst Count
  • AIV 1
  • PCRX 5
  • Target Price
  • AIV $10.00
  • PCRX $32.40
  • AVG Volume (30 Days)
  • AIV 2.3M
  • PCRX 543.2K
  • Earning Date
  • AIV 11-06-2025
  • PCRX 11-05-2025
  • Dividend Yield
  • AIV 37.38%
  • PCRX N/A
  • EPS Growth
  • AIV N/A
  • PCRX N/A
  • EPS
  • AIV N/A
  • PCRX N/A
  • Revenue
  • AIV $212,439,000.00
  • PCRX $705,848,000.00
  • Revenue This Year
  • AIV $6.96
  • PCRX $7.36
  • Revenue Next Year
  • AIV N/A
  • PCRX $10.07
  • P/E Ratio
  • AIV N/A
  • PCRX N/A
  • Revenue Growth
  • AIV 7.07
  • PCRX 2.25
  • 52 Week Low
  • AIV $6.89
  • PCRX $15.16
  • 52 Week High
  • AIV $9.29
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • AIV 41.92
  • PCRX 31.21
  • Support Level
  • AIV $7.67
  • PCRX $24.31
  • Resistance Level
  • AIV $8.00
  • PCRX $26.05
  • Average True Range (ATR)
  • AIV 0.17
  • PCRX 0.72
  • MACD
  • AIV -0.00
  • PCRX -0.35
  • Stochastic Oscillator
  • AIV 3.23
  • PCRX 1.56

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: